Skip to content

Clinical trials

Observational Hypertension, Portal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Portal Phase: Observational Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20072
20091
20101
20111
20123
20135
20141
20155
20164
20179
20189
20197
202012
202113
20228
202315
20247
20255
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status43
Completed42
Recruiting26
Not yet recruiting13
Active, not recruiting5
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Zhongshan Hospital10
Hepatopancreatobiliary Surgery Institute of Gansu Province9
Northern Jiangsu People's Hospital6
University Hospital, Bonn6
Nanfang Hospital, Southern Medical University5
Assiut University4
Post Graduate Institute of Medical Education and Research, Chandigarh4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Hvidovre University Hospital3
Medical University of Vienna3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Portal132
Liver Cirrhosis56
Fibrosis35
Esophageal and Gastric Varices16
Liver Diseases9
Carcinoma, Hepatocellular6
Ascites5
Hepatic Encephalopathy5
Hypersplenism4
Acute-On-Chronic Liver Failure3

Trials

Showing 76 to 100 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.